Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma-MedSci.cn

Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma

Yang, HY; Xiang, B; Song, YQ; Zhang, HL; Zhao, WL; Zou, DH; Lv, FF; Guo, W; Liu, AC; Li, CX; Tan, ZW; Liu, Y; Fu, LN; Guo, HY; Novotny, W; Huang, J; Li, YF

Li, YF (通讯作者)，127 Dongming Rd, Zhengzhou 450008, Henan, Peoples R China.

BLOOD ADVANCES, 2022; 6 (6): 1629

Abstract

The non-germinal center B-cell like (non-GCB) subtype of diffuse large B-cell lymphoma (DLBCL) has poor clinical outcomes. Bruton tyrosine kinase (BTK......

Full Text Link